In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 553-556

  Eick, Sigrun ^a   Schmitt, Andrea ^a   Sachse, Svea ^a   Schmidt, Karl Hermann ^a   Pfister, Wolfgang ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

GyrA; P. gingivalis; Periodontitis; Quinolones

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; GATIFLOXACIN; MOXIFLOXACIN; PHENYLALANINE; PROTEIN PARC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SERINE;

AGAR GEL DIFFUSION; AMINO ACID SUBSTITUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TARGETING; GENE SEQUENCE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MUTATION RATE; NONHUMAN; NUCLEOTIDE SEQUENCE; PORPHYROMONAS GINGIVALIS; PREDICTION; SERUM BACTERICIDAL ACTIVITY; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BACTEROIDACEAE INFECTIONS; DNA GYRASE; DNA PRIMERS; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; QUINOLINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 4444227633     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh354     Document Type: Article

References (10)

1. Lamont, R. J. & Jenkinson, H. F. (1998). Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Review. Microbiology and Molecular Biology Reviews 62,1244-63.
2. Walker, C. & Karpinia, K. (2002). Rationale for use of antibiotics in periodontics. Journal of Periodontology 73, 1267-72.
3. Dalhoff, A. & Schmitz, F. J. (2003). In vitro antibacterial activity and pharmacodynamics of new quinolones. Review. European Journal of Clinical Microbiology & Infectious Diseases 22, 203-21.
4. Pestova, E., Millichap, J. J., Noskin, G. A. et al. (2000). Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones. Journal of Antimicrobial Chemotherapy 45, 583-90.
5. Andrews, J. M. & Wise, R. (2000). Comparison of the Etest with a conventional agar dilution method evaluating the in vitro activity of moxifloxacin. Journal of Antimicrobial Chemotherapy 45, 257-8.
6. Firsov, A. A., Vostrov, S. N., Lubenko, I. Y. et al. (2003). In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 47, 1604-13.
7. Gradelski, E., Kolek, B., Bonner, D. et al. (2002). Bactericidal mechanism of gatifloxacin compared with other quinolones. Journal of Antimicrobial Chemotherapy 49, 185-8.
8. Ikeda, T. & Yoshimura, F. (2002). A resistance-nodulation-cell division family xenobiotic efflux pump in an obligate anaerobe, Porphyromonas gingivalis. Antimicrobial Agents and Chemotherapy 46, 3257-60.
9. Quiang, Y. Z., Qin, T., Fu, W. et al. (2002). Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli. Journal of Antimicrobial Chemotherapy 49, 549-52.
10. Hooper, D. C. (2001). Emerging mechanisms of fluoroquinolone resistance. Emerging Infectious Diseases 7, 337-41.